Shop - SLU-PP-332 10MG (Injectable)

Description

METABOLIC BOOST (SLU-PP-332)

SLU-PP-332 is a synthetic compound that has attracted considerable attention for its potential benefits, particularly in the areas of metabolic health and weight control.

Why is it worth it?

• the most advanced product for the reduction of excess weight
• accelerates the metabolic rate and forces the use of fatty acids as an energy source
• puts the body in a state induced by exercise or fasting
• Protects the heart and liver 
• improves endurance and performance by up to 70%
• has no effect on appetite

Here are the key benefits associated with SLU-PP-332 :

Weight loss: SLU-PP-332 has shown the ability to promote weight loss in experimental studies, mainly in mice. It has been shown to help mice lose a significant percentage of body weight without affecting appetite or food intake

https://www.eurekalert.org/news-releases/1002687

Fat reduction: SLU-PP-332 administration is associated with a significant reduction in body fat mass without a corresponding decrease in overall body weight. This suggests that it may specifically target fat accumulation

https://www.labroots.com/trending/cardiology/26023/unlocking-potential-exercise-pill-err-agonist-slu-pp-332

Preservation of muscle mass: One notable advantage of SLU-PP-332 is its potential to maintain muscle mass during weight loss, which is often a challenge in traditional weight loss efforts

https://bnn.network/breaking-news/health/new-exercise-mimicking-drug-a-potential-game-changer-in-treating-obesity-diabetes-and-muscle-loss/

Exercise mimicry: SLU-PP-332 has been described as an exercise-mimicking drug. It appears to replicate some of the metabolic benefits typically associated with exercise, making it a potential option for people who cannot engage in physical activity or as an adjunct to exercise routines

https://www.technologynetworks.com/drug-discovery/news/exercise-mimicking-drug-helps-mice-lose-weight-and-boost-endurance-379473

Metabolic syndrome mitigation: Studies suggest that SLU-PP-332 may alleviate metabolic syndrome, a group of conditions that increase the risk of heart disease, stroke and type 2 diabetes

https://jpet.aspetjournals.org/content/early/2023/09/22/jpet.123.001733